1. Home
  2. MYGN vs OSW Comparison

MYGN vs OSW Comparison

Compare MYGN & OSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYGN
  • OSW
  • Stock Information
  • Founded
  • MYGN 1991
  • OSW N/A
  • Country
  • MYGN United States
  • OSW Bahamas
  • Employees
  • MYGN N/A
  • OSW N/A
  • Industry
  • MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • OSW Hotels/Resorts
  • Sector
  • MYGN Health Care
  • OSW Consumer Discretionary
  • Exchange
  • MYGN Nasdaq
  • OSW Nasdaq
  • Market Cap
  • MYGN 2.0B
  • OSW 2.0B
  • IPO Year
  • MYGN 1995
  • OSW N/A
  • Fundamental
  • Price
  • MYGN $17.31
  • OSW $19.31
  • Analyst Decision
  • MYGN Buy
  • OSW Strong Buy
  • Analyst Count
  • MYGN 12
  • OSW 4
  • Target Price
  • MYGN $27.64
  • OSW $18.75
  • AVG Volume (30 Days)
  • MYGN 874.8K
  • OSW 549.8K
  • Earning Date
  • MYGN 11-07-2024
  • OSW 10-30-2024
  • Dividend Yield
  • MYGN N/A
  • OSW 0.42%
  • EPS Growth
  • MYGN N/A
  • OSW 2284.58
  • EPS
  • MYGN N/A
  • OSW 0.50
  • Revenue
  • MYGN $823,600,000.00
  • OSW $872,619,000.00
  • Revenue This Year
  • MYGN $13.85
  • OSW $13.37
  • Revenue Next Year
  • MYGN $7.73
  • OSW $9.04
  • P/E Ratio
  • MYGN N/A
  • OSW $38.25
  • Revenue Growth
  • MYGN 12.15
  • OSW 13.60
  • 52 Week Low
  • MYGN $16.10
  • OSW $11.02
  • 52 Week High
  • MYGN $29.30
  • OSW $19.31
  • Technical
  • Relative Strength Index (RSI)
  • MYGN 21.26
  • OSW 74.98
  • Support Level
  • MYGN $16.86
  • OSW $18.88
  • Resistance Level
  • MYGN $19.60
  • OSW $19.20
  • Average True Range (ATR)
  • MYGN 1.14
  • OSW 0.50
  • MACD
  • MYGN -0.31
  • OSW 0.16
  • Stochastic Oscillator
  • MYGN 7.32
  • OSW 100.00

About MYGN Myriad Genetics Inc.

Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.

About OSW OneSpaWorld Holdings Limited

OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts worldwide. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.

Share on Social Networks: